Effect of PAF-acether in non-human primates.
Arnoux
B
B
INSERM U 200, Clamart, France.
Denjean
A
A
Benveniste
J
J
D000403:Airway Resistance; D000818:Animals; D001249:Asthma / Q000209:etiology; D001986:Bronchial Spasm / Q000188:drug therapy / Q000209:etiology*; D003251:Constriction, Pathologic / Q000188:drug therapy / Q000209:etiology; D004205:Cromolyn Sodium / Q000627:therapeutic use; D007665:Ketotifen / Q000627:therapeutic use; D008170:Lung Compliance; D008176:Lung Volume Measurements; D017835:Nedocromil; D010215:Papio; D010972:Platelet Activating Factor; D011804:Quinolines / Q000627:therapeutic use
D010972:Platelet Activating Factor; D011804:Quinolines; D017835:Nedocromil; D004205:Cromolyn Sodium; D007665:Ketotifen